138 related articles for article (PubMed ID: 12063634)
1. Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.
Zatelli MC; Tagliati F; Taylor JE; Piccin D; Culler MD; degli Uberti EC
Horm Metab Res; 2002 May; 34(5):229-33. PubMed ID: 12063634
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; Vignali C; Margutti A; Bondanelli M; Pansini GC; Pelizzo MR; Culler MD; Degli Uberti EC
J Clin Endocrinol Metab; 2006 Jun; 91(6):2218-24. PubMed ID: 16569735
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt.
Zatelli MC; Tagliati F; Taylor JE; Rossi R; Culler MD; degli Uberti EC
J Clin Endocrinol Metab; 2001 May; 86(5):2161-9. PubMed ID: 11344221
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line.
Zatelli MC; Tagliati F; Piccin D; Taylor JE; Culler MD; Bondanelli M; degli Uberti EC
Biochem Biophys Res Commun; 2002 Oct; 297(4):828-34. PubMed ID: 12359227
[TBL] [Abstract][Full Text] [Related]
5. Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro.
Tagliati F; Zatelli MC; Bottoni A; Piccin D; Luchin A; Culler MD; Degli Uberti EC
Endocrinology; 2006 Jul; 147(7):3530-8. PubMed ID: 16601140
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
[TBL] [Abstract][Full Text] [Related]
7. An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro.
Zatelli MC; Piccin D; Bondanelli M; Tagliati F; De Carlo E; Culler MD; Uberti EC
Horm Metab Res; 2003 Jun; 35(6):349-54. PubMed ID: 12920656
[TBL] [Abstract][Full Text] [Related]
8. The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT.
Bläker M; Arrenberg P; Stange I; Schulz M; Burghardt S; Michaelis H; Pace A; Greten H; von Schrenck T; de Weerth A
Regul Pept; 2004 Apr; 118(1-2):111-7. PubMed ID: 14759564
[TBL] [Abstract][Full Text] [Related]
9. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.
Cassoni P; Muccioli G; Marrocco T; Volante M; Allia E; Ghigo E; Deghenghi R; Papotti M
J Endocrinol Invest; 2002 Apr; 25(4):362-8. PubMed ID: 12030609
[TBL] [Abstract][Full Text] [Related]
10. Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin a secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro.
Zatelli MC; Piccin D; Bottoni A; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Taylor JE; Culler MD; Cavazzini L; degli Uberti EC
J Clin Endocrinol Metab; 2004 Oct; 89(10):5181-8. PubMed ID: 15472224
[TBL] [Abstract][Full Text] [Related]
11. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid.
Zatelli MC; Maffei P; Piccin D; Martini C; Rea F; Rubello D; Margutti A; Culler MD; Sicolo N; degli Uberti EC
J Clin Endocrinol Metab; 2005 Apr; 90(4):2104-9. PubMed ID: 15671091
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin receptor mRNA expression in TT cells: effect of dexamethasone.
Frendo JL; Delage-Mourroux R; Cohen R; Pichaud F; Pidoux E; Guliana JM; Jullienne A
Mol Cell Endocrinol; 1998 Apr; 139(1-2):37-43. PubMed ID: 9705072
[TBL] [Abstract][Full Text] [Related]
14. The intratumoral immunoassayable somatostatin concentration is frequently elevated in medullary thyroid carcinoma. Results in 34 cases.
Modigliani E; Alamowitch C; Cohen R; Calmettes C; Guliana JM; Franc B; Bernard C; Chayvialle JA
Cancer; 1990 Jan; 65(2):224-8. PubMed ID: 1967221
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
Ain KB; Taylor KD; Tofiq S; Venkataraman G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
[TBL] [Abstract][Full Text] [Related]
16. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
Jaquet P; Saveanu A; Gunz G; Fina F; Zamora AJ; Grino M; Culler MD; Moreau JP; Enjalbert A; Ouafik LH
J Clin Endocrinol Metab; 2000 Feb; 85(2):781-92. PubMed ID: 10690891
[TBL] [Abstract][Full Text] [Related]
17. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
Jaquet P; Gunz G; Saveanu A; Barlier A; Dufour H; Taylor J; Dong J; Kim S; Moreau JP; Culler MD
J Endocrinol Invest; 2005; 28(11 Suppl International):21-7. PubMed ID: 16625841
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors: from basic science to clinical approach--thyroid.
Zatelli MC; degli Uberti EC
Dig Liver Dis; 2004 Feb; 36 Suppl 1():S86-92. PubMed ID: 15077916
[TBL] [Abstract][Full Text] [Related]
19. Effect of octreotide on expression of calcitonin gene in cultured cells of medullary thyroid carcinoma.
Zabel M
Histol Histopathol; 2004 Jul; 19(3):793-7. PubMed ID: 15168342
[TBL] [Abstract][Full Text] [Related]
20. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
